Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;136(3):jcs260243.
doi: 10.1242/jcs.260243. Epub 2023 Feb 6.

SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells

Affiliations

SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells

Lilian M Sluimer et al. J Cell Sci. .

Abstract

High expression of the non-receptor tyrosine kinase FER is an independent prognostic factor that correlates with poor survival in breast cancer patients. To investigate whether the kinase activity of FER is essential for its oncogenic properties, we developed an ATP analogue-sensitive knock-in allele (FERASKI). Specific FER kinase inhibition in MDA-MB-231 cells reduces migration and invasion, as well as metastasis when xenografted into a mouse model of breast cancer. Using the FERASKI system, we identified Ski family transcriptional corepressor 1 (SKOR1) as a direct FER kinase substrate. SKOR1 loss phenocopies FER inhibition, leading to impaired proliferation, migration and invasion, and inhibition of breast cancer growth and metastasis formation in mice. We show that SKOR1 Y234, a candidate FER phosphorylation site, is essential for FER-dependent tumor progression. Finally, our work suggests that the SKOR1 Y234 residue promotes Smad2/3 signaling through SKOR1 binding to Smad3. Our study thus identifies SKOR1 as a mediator of FER-dependent progression of high-risk breast cancers.

Keywords: Analogue-sensitive; Breast cancer; CRISPR-Cas9; FER tyrosine kinase; Metastasis; SKOR1.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare no competing or financial interests.

Publication types

Substances

LinkOut - more resources